[go: up one dir, main page]

ES537487A0 - Un procedimiento para la preparacion de oxazolidinas - Google Patents

Un procedimiento para la preparacion de oxazolidinas

Info

Publication number
ES537487A0
ES537487A0 ES537487A ES537487A ES537487A0 ES 537487 A0 ES537487 A0 ES 537487A0 ES 537487 A ES537487 A ES 537487A ES 537487 A ES537487 A ES 537487A ES 537487 A0 ES537487 A0 ES 537487A0
Authority
ES
Spain
Prior art keywords
oxazolidines
procedure
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES537487A
Other languages
English (en)
Other versions
ES8606863A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH6070/83A external-priority patent/CH655931A5/de
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of ES537487A0 publication Critical patent/ES537487A0/es
Publication of ES8606863A1 publication Critical patent/ES8606863A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D263/06Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by oxygen atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ES537487A 1983-11-10 1984-11-08 Un procedimiento para la preparacion de oxazolidinas Expired ES8606863A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH6070/83A CH655931A5 (en) 1983-11-10 1983-11-10 Oxazolidines
CH449984 1984-09-20

Publications (2)

Publication Number Publication Date
ES537487A0 true ES537487A0 (es) 1986-05-01
ES8606863A1 ES8606863A1 (es) 1986-05-01

Family

ID=25695620

Family Applications (1)

Application Number Title Priority Date Filing Date
ES537487A Expired ES8606863A1 (es) 1983-11-10 1984-11-08 Un procedimiento para la preparacion de oxazolidinas

Country Status (22)

Country Link
US (2) US4743604A (es)
AT (1) AT387771B (es)
AU (1) AU576531B2 (es)
BE (1) BE900983A (es)
CA (1) CA1249992A (es)
DE (1) DE3438411A1 (es)
DK (1) DK520584A (es)
ES (1) ES8606863A1 (es)
FI (1) FI844152L (es)
FR (1) FR2554814B1 (es)
GB (1) GB2149405B (es)
HU (1) HU193465B (es)
IL (1) IL73427A (es)
IT (1) IT1177033B (es)
LU (1) LU85631A1 (es)
MC (1) MC1641A1 (es)
NL (1) NL8403308A (es)
NO (1) NO844501L (es)
NZ (1) NZ210105A (es)
PH (1) PH22462A (es)
PT (1) PT79485B (es)
SE (1) SE463099B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU203330B (en) * 1987-06-10 1991-07-29 Pfizer Process for producing oxazolidin-2-one derivatives and hypoglychemic pharmaceutical compositions containing them
FI892341L (fi) * 1988-06-10 1989-12-11 Hoffmann La Roche Propanolaminderivat.
US5321036A (en) * 1993-02-10 1994-06-14 Bristol-Myers Squibb Company Thiazole and oxazole-based β3 adrenergic receptor agonists
US5563171A (en) * 1993-11-05 1996-10-08 American Cyanamid Company Treatment of glaucoma and ocular hypertension with β3-adrenergic agonists
US5578638A (en) * 1993-11-05 1996-11-26 American Cyanamid Company Treatment of glaucoma and ocular hypertension with β3 -adrenergic agonists
SK111195A3 (en) * 1994-09-13 1997-06-04 Sandoz Technology Ltd Bicyclic ethers substituted with oxazole and thiazole, process for producing thereof and pharmaceutical composition containing same
US7510849B2 (en) * 2004-01-29 2009-03-31 Glucolight Corporation OCT based method for diagnosis and therapy
US7254429B2 (en) 2004-08-11 2007-08-07 Glucolight Corporation Method and apparatus for monitoring glucose levels in a biological tissue
US8036727B2 (en) 2004-08-11 2011-10-11 Glt Acquisition Corp. Methods for noninvasively measuring analyte levels in a subject
AU2006235535A1 (en) 2005-04-13 2006-10-19 Glt Acquisition Corp. Method for data reduction and calibration of an OCT-based blood glucose monitor
US8571617B2 (en) * 2008-03-04 2013-10-29 Glt Acquisition Corp. Flowometry in optical coherence tomography for analyte level estimation
US9784726B2 (en) 2013-01-08 2017-10-10 Atrogi Ab Screening method, a kit, a method of treatment and a compound for use in a method of treatment
GB201714734D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714740D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714745D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714736D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201903832D0 (en) 2019-03-20 2019-05-01 Atrogi Ab New compounds and methods
GB202205895D0 (en) 2022-04-22 2022-06-08 Atrogi Ab New medical uses

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA979912A (en) * 1970-06-22 1975-12-16 Frederic P. Hauck Tetrahydronaphthyloxyaminopropanols and related compounds
GB1301134A (en) * 1970-07-18 1972-12-29 Pfizer Ltd SUBSTITUTED 1-PHENYL-2-ALLYLAMINO-ALKANOLS, 1-PHENYL-2-ALLYLAMINO-ALKANES AND alpha-AMINOALKYLPHENYL KETONES

Also Published As

Publication number Publication date
SE8405632L (sv) 1985-05-11
GB2149405B (en) 1987-07-01
IT8423307A0 (it) 1984-10-25
FI844152A7 (fi) 1985-05-11
IT8423307A1 (it) 1986-04-25
IL73427A (en) 1988-02-29
AU576531B2 (en) 1988-09-01
NO844501L (no) 1985-05-13
ATA355384A (de) 1988-08-15
FI844152A0 (fi) 1984-10-22
US4743604A (en) 1988-05-10
MC1641A1 (fr) 1986-01-09
CA1249992A (en) 1989-02-14
DK520584A (da) 1985-05-11
FR2554814B1 (fr) 1988-03-11
NL8403308A (nl) 1985-06-03
LU85631A1 (fr) 1986-06-04
HUT36103A (en) 1985-08-28
SE8405632D0 (sv) 1984-11-09
ES8606863A1 (es) 1986-05-01
IL73427A0 (en) 1985-02-28
IT1177033B (it) 1987-08-26
NZ210105A (en) 1988-10-28
PT79485A (en) 1984-12-01
HU193465B (en) 1987-10-28
AT387771B (de) 1989-03-10
AU3527584A (en) 1985-05-16
SE463099B (sv) 1990-10-08
FR2554814A1 (fr) 1985-05-17
GB2149405A (en) 1985-06-12
BE900983A (fr) 1985-05-06
DK520584D0 (da) 1984-11-01
DE3438411A1 (de) 1985-05-30
US4871755A (en) 1989-10-03
FI844152L (fi) 1985-05-11
GB8428335D0 (en) 1984-12-19
PT79485B (en) 1987-01-13
PH22462A (en) 1988-09-12

Similar Documents

Publication Publication Date Title
ES540812A0 (es) Un procedimiento para la preparacion de nuevos derivados delaminometil-oxooxazolidinil-benceno
ES554935A0 (es) Un procedimiento para la preparacion de pirazolo- y piridazo-pirazolinas, -piridazinas y -diacepinas
ES548672A0 (es) Un procedimiento para la preparacion de un derivado de dihi-dropiridina
ES541229A0 (es) Un procedimiento para la preparacion de nuevos derivados delcromano
ES537487A0 (es) Un procedimiento para la preparacion de oxazolidinas
ES543646A0 (es) Un procedimiento para la preparacion de derivados esteroida-les
ES541386A0 (es) Un procedimiento para la preparacion de un compuesto
ES544140A0 (es) Un procedimiento para la preparacion de nuevos derivados de benzotiazina
ES524399A0 (es) Un procedimiento para la preparacion de derivados de milbenicina d
ES530153A0 (es) Un procedimiento para la preparacion de compuestos de beta-lactama
ES532172A0 (es) Un procedimiento para la preparacion de derivados de pirimidona
ES544250A0 (es) Un procedimiento para la preparacion de benzoquinolicinas
ES535392A0 (es) Un procedimiento para la preparacion de derivados de imidazobenzodiacepina
ES540347A0 (es) Un procedimiento para la preparacion de derivados de piperi-dina
ES535492A0 (es) Un procedimiento para la preparacion de un compuesto de b-lactama
ES546356A0 (es) Un procedimiento para la preparacion de nuevos derivados delacido tiazolilacetico
ES545776A0 (es) Un procedimiento para la preparacion de nuevos derivados de feniletanamina
ES527804A0 (es) Un procedimiento para la preparacion de derivados de oxacefalosporina
ES531498A0 (es) Un procedimiento para la preparacion de derivados de pirimidinatriona
ES538699A0 (es) Un procedimiento para la preparacion de derivados de 1-normon-2-ilo
ES531528A0 (es) Un procedimiento para la preparacion de un compuesto
ES537782A0 (es) Un procedimiento para la preparacion de 2-cloro-3-trifluorme-tilbenzaldehido
ES535101A0 (es) Un procedimiento para la preparacion de nuevos derivados de pirrol-2-acetilaminoacido
ES526294A0 (es) Un procedimiento para la preparacion de derivados pentaciclicos
ES526400A0 (es) Un procedimiento para la preparacion de pirrolopirroles